Try our beta test site

Tepilta® Versus Oxetacaine, Antacids and Placebo

This study has been terminated.
(The study stopped prematurely due to and administrative reasons, not based on grounds of safety.)
Sponsor:
Collaborators:
Trium Analysis Online GmbH
ICON plc
Clinipace Worldwide
Information provided by (Responsible Party):
MEDA Pharma GmbH & Co. KG
ClinicalTrials.gov Identifier:
NCT01336530
First received: April 1, 2011
Last updated: March 2, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2017
  Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)